The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy Research Letter

  

Authors:	Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z.; Menghrajani, K. N.; Glass, J. L.; Taylor, J.; Viny, A. D.; Giralt, S. S.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Levine, R. L.; Tallman, M. S.; Stein, E. M.
Title:	The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
Journal Title:	American Journal of Hematology
Volume:	96
Issue:	5
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2021-05-01
Start Page:	E171
End Page:	E175
Language:	English
DOI:	10.1002/ajh.26146
PUBMED:	33650111
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102933035&doi=10.1002%2fajh.26146&partnerID=40&md5=9e7176dd686df79d97e4ef32c47752d7
Notes:	Letter -- Export Date: 3 May 2021 -- Source: Scopus